Chronic Myeloid Leukemia, BCR-ABL1+
About
Mappings
NCI Thesaurus: Chronic Myeloid Leukemia, BCR-ABL1 Positive (coding:ncit:C3174)
OncoTree: Chronic Myeloid Leukemia, BCR-ABL1+ (coding:oncotree:CMLBCRABL1)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (4) HC (1) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Asciminib | |
| FDA (2) | ABL1 p.T315I, BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Asciminib | |
| FDA (4) HC (2) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Bosutinib | |
| FDA (6) HC (2) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Dasatinib | |
| FDA (4) HC (2) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Imatinib | |
| FDA (6) HC (4) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Nilotinib | |
| FDA (2) HC (1) | ABL1 p.T315I, BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Ponatinib |